These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30593674)

  • 41. Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.
    Goulding R; Dawes D; Price M; Wilkie S; Dawes M
    Br J Clin Pharmacol; 2015 Oct; 80(4):868-77. PubMed ID: 25060532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Terrenato I; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006466. PubMed ID: 21154368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal loading dose for the initiation of warfarin: a systematic review.
    Heneghan C; Tyndel S; Bankhead C; Wan Y; Keeling D; Perera R; Ward A
    BMC Cardiovasc Disord; 2010 Apr; 10():18. PubMed ID: 20403189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
    Vestergaard AS; Skjøth F; Larsen TB; Ehlers LH
    PLoS One; 2017; 12(11):e0188482. PubMed ID: 29155884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.
    Katada Y; Nakagawa S; Minakata K; Odaka M; Taue H; Sato Y; Yonezawa A; Kayano Y; Yano I; Nakatsu T; Sakamoto K; Uehara K; Sakaguchi H; Yamazaki K; Minatoya K; Sakata R; Matsubara K
    J Clin Pharm Ther; 2017 Oct; 42(5):591-597. PubMed ID: 28503837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.
    McMillin GA; Melis R; Wilson A; Strong MB; Wanner NA; Vinik RG; Peters CL; Pendleton RC
    Ther Drug Monit; 2010 Jun; 32(3):338-45. PubMed ID: 20386359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens.
    Providência R; Grove EL; Husted S; Barra S; Boveda S; Morais J
    Thromb Res; 2014 Dec; 134(6):1253-64. PubMed ID: 25457584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotype-guided dosing of warfarin through modeling and simulation.
    Deng J; Vozmediano V; Rodriguez M; Cavallari LH; Schmidt S
    Eur J Pharm Sci; 2017 Nov; 109S():S9-S14. PubMed ID: 28502675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-Utility Study of Warfarin Genotyping in the VACHS Affiliated Anticoagulation Clinic of Puerto Rico.
    Martes-Martinez C; Méndez-Sepúlveda C; Millán-Molina J; French-Kim M; Marín-Centeno H; Rivera-Miranda GC; Hernández-Muñoz JJ; Duconge-Soler J
    P R Health Sci J; 2017 Sep; 36(3):165-172. PubMed ID: 28915306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initiating warfarin therapy: 5 mg versus 10 mg.
    Eckhoff CD; Didomenico RJ; Shapiro NL
    Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
    Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
    Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
    Schwartz JB; Kane L; Moore K; Wu AH
    J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study.
    Jorgensen AL; Prince C; Fitzgerald G; Hanson A; Downing J; Reynolds J; Zhang JE; Alfirevic A; Pirmohamed M
    BMC Med; 2019 Apr; 17(1):76. PubMed ID: 30961588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
    Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
    Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of renal insufficiency on anticoagulant effects and safety of warfarin in Chinese patients: analysis from a randomized controlled trial.
    Ning X; Kuang Y; Yang G; Xie J; Miao D; Guo C; Huang Z
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1275-1283. PubMed ID: 33404689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
    Cho SM; Lee KY; Choi JR; Lee KA
    Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical applications of pharmacogenomics guided warfarin dosing.
    Mahajan P; Meyer KS; Wall GC; Price HJ
    Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized trial of initial warfarin dosing based on simple clinical criteria.
    Shine D; Patel J; Kumar J; Malik A; Jaeger J; Maida M; Ord L; Burrows G
    Thromb Haemost; 2003 Feb; 89(2):297-304. PubMed ID: 12574810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.